Rapid COVID-19 test, Oxsed RaViD Direct, now in use at Heathrow and trials at Hong Kong International Airport
4 November 2020
The spinout company, Oxsed, was last month acquired by DNAFit Life Sciences, a wholly owned entity of Hong Kong-based genetics and diagnostic health testing company Prenetics. Deploying the test to further global airports is now under discussion.
28 October 2020
PhishAR builds on the work of Professor Ivan Martinovic and Dr Ivo Sluganovic from the Department of Computer Science, and employs augmented reality to crack down on “phishing”.
11 May 2018
Researchers in the Department of Chemistry have developed a crop stimulant that increases yields by 20%.
13 March 2018
OxSyBio, an Oxford University biotech spinout company developing 3D printer technology capable of printing biological materials with a diverse range of therapeutic purposes, has secured £10m in Series A financing from Woodford Investment Management alongside new and existing backers.
20 October 2017
In stopping disease, early diagnosis is key, but hampered by expensive and time consuming blood tests. But what if we could diagnose disease as easily as we can measure glucose levels? Article by Gregg Bayes-Brown, Marketing and Communications Manager, Oxford University Innovation.